Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03899844 · ClinicalTrials.gov registry record
Study to Evaluate Amyloid in Blood and Imaging Related to Dementia
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 1,122
- Enrollment target
NCT03899844: Completed study, sponsored by Washington University School of Medicine.
NCT03899844 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 1,122 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03899844 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 1,122 participants
- Enrollment target
Study Summary
The purpose of this study is to determine how well a blood test can detect amyloid beta, a protein involved in Alzheimer's disease. Participants will be asked to complete an initial blood collection and cognitive testing, and a subset of participants will be asked to complete a larger blood collection, amyloid PET imaging, and an MRI.
Interventions
- OTHER Blood collection, PiB PET/MRI, and cognitive testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,122 participants |
| Start Date | 2019-04-09 |
| Est. Completion | 2024-01-31 |
What the finished NCT03899844 record still lists
NCT03899844 is an observational study that tracks outcomes without assigning an intervention. Its 1,122 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Blood collection, PiB PET/MRI, and cognitive testing is the first listed.
NCT03899844 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03899844 about?
NCT03899844 is a clinical study titled "Study to Evaluate Amyloid in Blood and Imaging Related to Dementia". The purpose of this study is to determine how well a blood test can detect amyloid beta, a protein involved in Alzheimer's disease. Participants will be asked to complete an initial blood collection and cognitive testing, and a subset of participants will be asked to complete a larger blood collecti...
What is the current status of trial NCT03899844?
This trial is currently completed. The enrollment target is 1,122 participants. The study started on 2019-04-09. Estimated completion is 2024-01-31.
What interventions are being tested in trial NCT03899844?
The interventions under investigation include: Blood collection, PiB PET/MRI, and cognitive testing (OTHER).
Who is sponsoring clinical trial NCT03899844?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05691478 · 1,122 participants · Phase 2
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
- NCT05438329 · 1,123 participants · Phase 1
First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors
- NCT06952504 · 1,123 participants · Phase 3
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- NCT02140255 · 1,120 participants · Phase 1
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI